Beginning on March 30, MedTech Intelligence will host a five-week EU IVDR Innovation in Practice Virtual Event that delves into the process, data, reporting and planning aspects of the regulation. Registration is complimentary, and each episode starts at 12 pm ET.
- March 30: An introduction to EU IVDR
- April 6: Quality Processes and Documentation
- April 13: Clinical Evidence & Surveillance (Sponsored by Evidence Partners)
- April 20: Supply Chain Management: Economic Operators, UDI and Labeling
- April 27: Strategy and Planning
The speaker lineup includes:
- Jon Marion, Associate Director, Good Clinical Practice, Abbott Quality & Regulatory, Abbott Laboratories
- Alex Charitou, Associate Partner, Ernst & Young Life Sciences Consulting / International MedTech Leader
- Geoffray Colson, Head RAQA EMEAC-LATAM, Hologic
- Cindy Ballas, IVDR Implentation Project Lead, Ortho Clinical Diagnostics
- Ravi Nabar, Head of Global QMS & Compliance, Illumina
- Bassil Akra, CEO, Qunique, former VP, TÜV SÜD
The program content is recommended for diagnostics company professionals in management, RA/QA, clinical, risk management, postmarket surveillance, labeling, compliance and auditing, legal, international affairs, policy, supply chain, global strategy, product management and project management.
Related Articles
-
The partnership brings together Evidence Partners' literature review platform, DistillerSR, and Akra Team's strategic regulatory services.
-
The European Commission developed the new proposal following a December 9, 2022, meeting of the EPSCO Council, where EU Ministers of Health called on the Commission to swiftly submit a proposal to extend the transition period in the Medical Device…
-
The only constant today is change itself.
-
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to concerns raised by medical device trade associations regarding future regulation of medical devices in the United Kingdom.
